Regeneron Pharmaceuticals REGN
NASDAQ REGN
$902.90 -27.77 (-2.98%)
At close: Nov 5, 2026 · 4:00 PM EST

Regeneron Pharmaceuticals (REGN) Notes Payables (2020)

Updated

Regeneron Pharmaceuticals (REGN) posted Short-Term Borrowings of $1.5 billion for Q2 2020.

Analysis

Regeneron Pharmaceuticals (REGN) Notes Payables (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,221.09 Bn 1,194.71 Bn 20.46 Bn
2 Johnson & Johnson 656.38 Bn 576.24 Bn 17.30 Bn
3 AbbVie 510.79 Bn 478.80 Bn 13.12 Bn
4 Merck 363.00 Bn 317.38 Bn 12.21 Bn
5 Novartis Ag 313.89 Bn 287.12 Bn -
6 Astrazeneca 290.02 Bn 263.91 Bn 13.26 Bn
7 Amgen 249.59 Bn 204.98 Bn 7.24 Bn
8 Gilead Sciences 208.15 Bn 183.26 Bn 6.73 Bn
9 Pfizer 170.74 Bn 118.10 Bn 12.56 Bn
10 Regeneron Pharmaceuticals 91.70 Bn 57.05 Bn 4.54 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 1.50 Bn
API Access

Regeneron Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=REGN&period=max&api_key=YOUR_API_KEY